tBrexa Bio Revenue

Pharmaceutical Manufacturing • Stoughton, Massachusetts, United States • 1-10 Employees

tBrexa Bio revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at tBrexa Bio

Leona Saunders

Founder & CEO at tBrexa Bio

Company overview

Headquarters	6 Cabot Pl, 4, Stoughton, Massachusetts 02072, US
NAICS	3254
Keywords	Biologics, Cdmo, Gene Therapy, Woman, Large Molecules, AVV, Usa-Owned
Founded	2017
Employees	1-10

tBrexa Bio Email Formats

tBrexa Bio uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@tbrexa.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@tbrexa.com	100%

About tBrexa Bio

Welcome to tBrexa Bio, an innovative start-up CDMO based in Massachusetts, dedicated to transforming the future of healthcare. Our mission is to advance the biopharmaceutical industry by providing state-of-the-art manufacturing solutions for cutting-edge therapies. As a contract development and manufacturing organization, we offer a comprehensive range of biologics manufacturing services, from process development to cGMP clinical and commercial manufacturing. Our expertise in biomanufacturing and quality control is paired with advanced capabilities in immunoassays, molecular assays, and bioanalytical methods, ensuring the highest standards in cell and gene-based therapies and large-molecule biologics production. Our services encompass clinical and commercial drug substance and drug product manufacturing, release and stability testing, and a variety of process development services, including upstream and downstream development and optimization, analytical method development, cell line development, testing, and characterization. With our planned Massachusetts facility set to open in 2025, we are poised to have a significant impact on the biotechnology sector. We are actively seeking strategic partners and funding to bring our vision to life and lead the way in biopharmaceutical innovation. 1. Manufacturing Expertise: We develop and produce clinical-grade materials, ensuring compliance with Good Manufacturing Practices (GMP) standards. 2. Regulatory Support: We have a dedicated team that will assist in preparing Investigational New Drug (IND) and marketing applications globally. We help you navigate complex regulatory pathways. 3. Commercialization Readiness: Strategic planning and technical assistance to streamline the transition from research to market, including scalability assessments and cost optimization. 4. 2025-2026 Life Science Incubator: tBrexa proposes the creation of a state-of-the-art Life Science Incubator within our newly identified facility.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

tBrexa Bio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

tBrexa Bio has never raised funding before.

Frequently asked questions

tBrexa Bio is located in Stoughton, Massachusetts, US.

tBrexa Bio generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

tBrexa Bio has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

tBrexa Bio was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

tBrexa Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at tBrexa Bio

Leona Saunders

Founder & CEO at tBrexa Bio

4.8

40,000 users